Scrip
ADVANCE-2 provides reassurance over apixaban
03 July 2009
Alex Shimmings
Please Login to read the full article.
03 July 2009
Alex Shimmings
Abstracts published online ahead of the International Society on Thrombosis and Hemostasis meeting in Boston later this month have provided some reassurance on the efficacy and safety profile of Pfizer/ Bristol-Myers Squibb's investigational Factor Xa inhibitor apixaban.
Headline...
Please Login to read the full article.
RELATED CONTENT
NEWS
- Daiichi Sankyo's edoxaban enters pivotal trial for VTE
- Daiichi Sankyo's edoxaban shows Phase III promise in orthopaedic setting
- FDA issues complete response letter for Bayer/J&J's Xarelto
- Xarelto stumbles on filing update but shines in long-term treatment for VTE risk reduction
COMMENT
Other Informa Comment
EVENTS
10 February 2010
London, UK
11 February 2010
London, UK
23 February 2010
London, UK
JOB OF THE WEEK
Promote your vacancy here
DIRECTORY
Scrip Directory 2009
